These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33321295)

  • 41. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
    van Eggermond AM; Schaapveld M; Janus CP; de Boer JP; Krol AD; Zijlstra JM; van der Maazen RW; Kremer LC; van Leerdam ME; Louwman MW; Visser O; De Bruin ML; Aleman BM; van Leeuwen FE
    Br J Cancer; 2017 Jul; 117(3):306-314. PubMed ID: 28632726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of Secondary Lung Cancer Among Hodgkin Lymphoma Survivors: A Nationwide Analysis.
    Alnimer Y; Ali MKM
    Clin Lung Cancer; 2022 Dec; 23(8):e510-e518. PubMed ID: 36008241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and histological features of second breast cancers following radiotherapy for childhood and young adult malignancy.
    Demoor-Goldschmidt C; Supiot S; Mahé MA; Oberlin O; Allodji R; Haddy N; Helfre S; Vigneron C; Brillaud-Meflah V; Bernier V; Laprie A; Ducassou A; Claude L; Diallo I; de Vathaire F
    Br J Radiol; 2018 Jun; 91(1086):20170824. PubMed ID: 29493262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
    Travis LB; Hill DA; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer MB; Glimelius I; Storm H; Pukkala E; Stovall M; Curtis R; Boice JD; Gilbert E
    JAMA; 2003 Jul; 290(4):465-75. PubMed ID: 12876089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis.
    Boukheris H; Ron E; Dores GM; Stovall M; Smith SA; Curtis RE
    Cancer; 2008 Dec; 113(11):3153-9. PubMed ID: 18823043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Second malignancy after treatment of pediatric Hodgkin disease.
    Lin HM; Teitell MA
    J Pediatr Hematol Oncol; 2005 Jan; 27(1):28-36. PubMed ID: 15654275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
    Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphisms of drug metabolizing enzymes and markers of genotoxicity to identify patients with Hodgkin's lymphoma at risk of treatment-related complications.
    Kelly KM; Perentesis JP;
    Ann Oncol; 2002; 13 Suppl 1():34-9. PubMed ID: 12078900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast Cancer and Mediastinal Hodgkin's Lymphomas: Multidisciplinary Discussion.
    Touati R; Pauly L; Reyal F; Kirova Y
    Clin Breast Cancer; 2023 Oct; 23(7):681-686. PubMed ID: 37419747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
    Hodgson DC; Gilbert ES; Dores GM; Schonfeld SJ; Lynch CF; Storm H; Hall P; Langmark F; Pukkala E; Andersson M; Kaijser M; Joensuu H; Fosså SD; Travis LB
    J Clin Oncol; 2007 Apr; 25(12):1489-97. PubMed ID: 17372278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies.
    Overholser L; Shagisultanova E; Rabinovitch RA; Kounalakis N; Diamond J; Finlayson CA; Fisher CM; Kabos P; Elias AD; Borges VF; Mayordomo J
    Oncology (Williston Park); 2016 Dec; 30(12):1063-70. PubMed ID: 27987198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
    Chang ET; Lau EC; Mowat FS; Teta MJ
    Cancer Causes Control; 2017 Sep; 28(9):971-979. PubMed ID: 28755241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers.
    Withrow DR; Morton LM; Curtis RE; Schonfeld SJ; Berrington de González A
    JAMA Oncol; 2018 Mar; 4(3):414-416. PubMed ID: 29346498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
    Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
    JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T; Liphshitz I; Silverman B; Polliack A
    Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
    Almagro-Casado E; Sánchez A; Cantos B; Salas C; Pérez-Callejo D; Provencio M
    Clin Transl Oncol; 2016 Jan; 18(1):99-106. PubMed ID: 26530956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hodgkin lymphoma: the follow-up of long-term survivors.
    Hodgson DC
    Hematol Oncol Clin North Am; 2008 Apr; 22(2):233-44, vi. PubMed ID: 18395147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
    Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ
    Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.